(Q35752708)

10 August 2017

1 reference

title

Gastroesophageal reflux disease: presentation and assessment of a common, challenging disorder (English)

1 reference

gastroesophageal reflux disease

10 August 2017

main subject

0 references

author name string

Andrew H Soll

series ordinal

1

1 reference

10 August 2017

Ronnie Fass

series ordinal

2

1 reference

10 August 2017

language of work or name

1 reference

1 January 2003

1 reference

10 August 2017

1 reference

10 August 2017

volume

5

1 reference

10 August 2017

issue

4

1 reference

10 August 2017

page(s)

2-14; discussion 14-7

1 reference

Non-erosive reflux disease (NERD)--acid reflux and symptom patterns

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990095-0

7 January 2021

Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990095-0

7 January 2021

Double blind cross-over placebo controlled study of omeprazole in the treatment of patients with reflux symptoms and physiological levels of acid reflux--the "sensitive oesophagus"

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990095-0

7 January 2021

Maximal acid reflux control for Barrett's oesophagus: feasible and effective

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990095-0

7 January 2021

Clinical characteristics and natural history of patients with low-grade reflux esophagitis

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990095-0

7 January 2021

Pathogenesis of gastroesophageal reflux disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990095-0

7 January 2021

Hiatal hernia size is the dominant determinant of esophagitis presence and severity in gastroesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990095-0

7 January 2021

Gastro-oesophageal reflux associated with nifedipine

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990095-0

7 January 2021

Gastro-oesophageal reflux disease in obesity: pathophysiological and therapeutic considerations

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990095-0

7 January 2021

Upright versus supine reflux in gastroesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990095-0

7 January 2021

Multichannel intraluminal impedance in esophageal function testing and gastroesophageal reflux monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990095-0

7 January 2021

Relaxation training reduces symptom reports and acid exposure in patients with gastroesophageal reflux disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990095-0

7 January 2021

Duodenal fat intensifies the perception of heartburn

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990095-0

7 January 2021

The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990095-0

7 January 2021

Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990095-0

7 January 2021

Effect of the pre-operative response to H2 receptor antagonists on the outcome of highly selective vagotomy for duodenal ulcer

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990095-0

7 January 2021

Do psychosocial factors define symptom severity and patient status in irritable bowel syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990095-0

7 January 2021

Difficult patient encounters in the ambulatory clinic: clinical predictors and outcomes.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2803%2990095-0

7 January 2021

10.1016/S1098-3597(03)90095-0

Identifiers

DOI

1 reference

10 August 2017

1 reference